MedTrace Logo

Hypotension Prediction Index Study (HPI Study)

NCT03805217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 485

Last updated 2024-10-18

No results posted yet for this study

Summary

A prospective, single-arm, open-label, multicenter post-approval study to determine whether the use of the Acumen HPI Software to guide intraoperative hemodynamic management in non-cardiac surgery reduces the duration of intraoperative hypotension below a threshold of Mean Arterial Pressure (MAP)

Conditions

Interventions

DEVICE

EV1000A Clinical Platform with Acumen Hypotension Prediction Index Feature Software

EV1000A Clinical Platform with Acumen Hypotension Prediction Index Feature Software

Sponsors & Collaborators

  • Edwards Lifesciences

    lead INDUSTRY

Principal Investigators

  • Tina Abdelnour, MS, BSN · Edwards Lifesciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-16
Primary Completion
2020-03-17
Completion
2020-03-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03805217 on ClinicalTrials.gov